Vowles Kevin E, McEntee Mindy L, Julnes Peter Siyahhan, Frohe Tessa, Ney John P, van der Goes David N
Department of Psychology, University of New Mexico, Albuquerque, NM, USA Department of Neurology, University of Washington, Seattle, WA, USA Department of Economics, University of New Mexico, Albuquerque, NM, USA.
Pain. 2015 Apr;156(4):569-576. doi: 10.1097/01.j.pain.0000460357.01998.f1.
Opioid use in chronic pain treatment is complex, as patients may derive both benefit and harm. Identification of individuals currently using opioids in a problematic way is important given the substantial recent increases in prescription rates and consequent increases in morbidity and mortality. The present review provides updated and expanded information regarding rates of problematic opioid use in chronic pain. Because previous reviews have indicated substantial variability in this literature, several steps were taken to enhance precision and utility. First, problematic use was coded using explicitly defined terms, referring to different patterns of use (ie, misuse, abuse, and addiction). Second, average prevalence rates were calculated and weighted by sample size and study quality. Third, the influence of differences in study methodology was examined. In total, data from 38 studies were included. Rates of problematic use were quite broad, ranging from <1% to 81% across studies. Across most calculations, rates of misuse averaged between 21% and 29% (range, 95% confidence interval [CI]: 13%-38%). Rates of addiction averaged between 8% and 12% (range, 95% CI: 3%-17%). Abuse was reported in only a single study. Only 1 difference emerged when study methods were examined, where rates of addiction were lower in studies that identified prevalence assessment as a primary, rather than secondary, objective. Although significant variability remains in this literature, this review provides guidance regarding possible average rates of opioid misuse and addiction and also highlights areas in need of further clarification.
阿片类药物用于慢性疼痛治疗的情况较为复杂,因为患者可能既受益也受害。鉴于近期处方率大幅上升以及随之而来的发病率和死亡率增加,识别目前以有问题方式使用阿片类药物的个体很重要。本综述提供了关于慢性疼痛中有问题阿片类药物使用发生率的最新且扩充的信息。由于先前的综述表明该文献存在很大差异,因此采取了几个步骤来提高准确性和实用性。首先,使用明确定义的术语对有问题的使用进行编码,这些术语指的是不同的使用模式(即误用、滥用和成瘾)。其次,计算平均流行率,并根据样本量和研究质量进行加权。第三,研究了研究方法差异的影响。总共纳入了38项研究的数据。有问题使用的发生率范围很广,各研究之间从<1%到81%不等。在大多数计算中,误用率平均在21%至29%之间(范围,95%置信区间[CI]:13%-38%)。成瘾率平均在8%至12%之间(范围,95%CI:3%-17%)。只有一项研究报告了滥用情况。在研究方法检查中仅出现了一个差异,即把患病率评估确定为主要而非次要目标的研究中,成瘾率较低。尽管该文献中仍存在显著差异,但本综述提供了关于阿片类药物误用和成瘾可能的平均发生率的指导,也突出了需要进一步澄清的领域。